Condition
Urogenital Abnormalities
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Early P 1 (1)
P 1 (1)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03718234Phase 1Completed
Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
NCT03898440CompletedPrimary
Fetal Ano-genital Distance in 2D Ultrasound.
NCT01493791Early Phase 1WithdrawnPrimary
CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women
NCT00758108Completed
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Showing all 4 trials